221 related articles for article (PubMed ID: 37489148)
21. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
22. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
[TBL] [Abstract][Full Text] [Related]
23. Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections.
Huenecke S; Cappel C; Esser R; Pfirrmann V; Salzmann-Manrique E; Betz S; Keitl E; Banisharif-Dehkordi J; Bakhtiar S; Königs C; Jarisch A; Soerensen J; Ullrich E; Klingebiel T; Bader P; Bremm M
Front Immunol; 2017; 8():109. PubMed ID: 28239380
[TBL] [Abstract][Full Text] [Related]
24. Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation.
Park KH; Ryu JH; Bae H; Yun S; Jang JH; Han K; Cho BS; Kim HJ; Lee H; Oh EJ
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455959
[TBL] [Abstract][Full Text] [Related]
25. Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis.
Troullioud Lucas AG; Lindemans CA; Bhoopalan SV; Dandis R; Prockop SE; Naik S; Keerthi D; de Koning C; Sharma A; Nierkens S; Boelens JJ
Cytotherapy; 2023 Sep; 25(9):977-985. PubMed ID: 37330731
[TBL] [Abstract][Full Text] [Related]
26. Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation.
Pradier A; Cordey S; Zanella MC; Melotti A; Wang S; Mamez AC; Chalandon Y; Masouridi-Levrat S; Kaiser L; Simonetta F; Vu DL
Front Immunol; 2022; 13():1060886. PubMed ID: 36713419
[TBL] [Abstract][Full Text] [Related]
27. Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy.
Chen W; Ma Y; Shen Z; Chen H; Ma R; Yan D; Shi M; Wang X; Song X; Sun C; Cao J; Cheng H; Zhu F; Sun H; Li D; Li Z; Zheng J; Xu K; Sang W
Front Immunol; 2021; 12():755549. PubMed ID: 34777367
[TBL] [Abstract][Full Text] [Related]
28. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between NK Cell Reconstitution and aGVHD after Allo-HSCT].
Wan LL; Chen JL; Xu C; Li BT; Hu JW; Lou X; Yang F; Liu N; Su YF; Lan SC; Wang QH; Qiao ZQ; Wang L; Jiang M; Li YH; Hu LD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):530-534. PubMed ID: 28446306
[TBL] [Abstract][Full Text] [Related]
30. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia.
Klyuchnikov E; Badbaran A; Massoud R; Fritsche-Friedland U; Janson D; Ayuk F; Wolschke C; Bacher U; Kröger N
Transplant Cell Ther; 2021 Oct; 27(10):841-850. PubMed ID: 34118468
[TBL] [Abstract][Full Text] [Related]
32. Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly Patients.
Cho BS; Yahng SA; Min GJ; Park S; Park SS; Shin SH; Jeon YW; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim M; Kim Y; Kim HJ
Transplant Cell Ther; 2021 Sep; 27(9):774.e1-774.e12. PubMed ID: 34082159
[TBL] [Abstract][Full Text] [Related]
33. Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation.
Haroun-Izquierdo A; Lanuza PM; Pfefferle A; Netskar H; Ask EH; Törlén J; Björklund A; Sohlberg E; Malmberg KJ
Transplant Cell Ther; 2023 Jun; 29(6):376.e1-376.e11. PubMed ID: 36966873
[TBL] [Abstract][Full Text] [Related]
34. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB
Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies: A Single-center Study].
Lu JP; Wen SP; Wang FX; Li SH; Niu ZY; Wang Y; Zhou ZW; Xu Z; Wang ZZ; Zhang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1238-1243. PubMed ID: 35981391
[TBL] [Abstract][Full Text] [Related]
36. Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
Makanga DR; Guillaume T; Willem C; Legrand N; Gagne K; Cesbron A; Gendzekhadze K; Peterlin P; Garnier A; Le Bourgeois A; Béné MC; Chevallier P; Retière C
J Immunol; 2020 Sep; 205(5):1441-1448. PubMed ID: 32747504
[TBL] [Abstract][Full Text] [Related]
37. Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous Recipients.
Nikoloudis A; Wagner H; Machherndl-Spandl S; Buxhofer-Ausch V; Strassl I; Stiefel O; Wipplinger D; Milanov R; Kaynak E; Hasengruber P; Binder M; Weltermann A; Petzer A; Wolf D; Nachbaur D; Clausen J
Transplant Cell Ther; 2021 Aug; 27(8):686.e1-686.e9. PubMed ID: 33991724
[TBL] [Abstract][Full Text] [Related]
38. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
39. αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies.
de Witte MA; Janssen A; Nijssen K; Karaiskaki F; Swanenberg L; van Rhenen A; Admiraal R; van der Wagen L; Minnema MC; Petersen E; Raymakers RAP; Westinga K; Straetemans T; Halkes CJM; Boelens JJ; Kuball J
Blood Adv; 2021 Jan; 5(1):240-249. PubMed ID: 33570642
[TBL] [Abstract][Full Text] [Related]
40. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]